Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer
A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without M6620 (VX-970) in Metastatic Urothelial Carcinoma
Sponsor: National Cancer Institute (NCI)
This PHASE2 trial investigates Metastatic Bladder Urothelial Carcinoma and Metastatic Renal Pelvis and Ureter Urothelial Carcinoma and is currently completed. National Cancer Institute (NCI) leads this study, which shows 53 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
53 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Apr 2025 — Sep 2025 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Nov 2024 — Apr 2025 [monthly]
Active Not Recruiting PHASE2
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
▶ Show 48 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
May 2024 — Jun 2024 [monthly]
Active Not Recruiting PHASE2
-
Feb 2024 — May 2024 [monthly]
Active Not Recruiting PHASE2
-
Dec 2023 — Feb 2024 [monthly]
Active Not Recruiting PHASE2
-
Nov 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE2
-
May 2023 — Nov 2023 [monthly]
Active Not Recruiting PHASE2
-
Feb 2023 — May 2023 [monthly]
Active Not Recruiting PHASE2
-
Sep 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE2
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
-
May 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE2
-
Apr 2022 — May 2022 [monthly]
Active Not Recruiting PHASE2
-
Oct 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE2
-
May 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Oct 2020 — Nov 2020 [monthly]
Active Not Recruiting PHASE2
-
Aug 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE2
-
Jul 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE2
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE2
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE2
-
Apr 2020 — May 2020 [monthly]
Active Not Recruiting PHASE2
-
Mar 2020 — Apr 2020 [monthly]
Active Not Recruiting PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting PHASE2
Status: Suspended → Active Not Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Suspended PHASE2
Status: Recruiting → Suspended
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE2
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE2
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE2
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE2
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE2
-
Apr 2019 — Jul 2019 [monthly]
Recruiting PHASE2
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE2
-
Dec 2018 — Mar 2019 [monthly]
Recruiting PHASE2
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE2
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE2
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Aug 2017 — Dec 2017 [monthly]
Recruiting PHASE2
-
Jun 2017 — Aug 2017 [monthly]
Recruiting PHASE2
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE2
-
Apr 2017 — May 2017 [monthly]
Recruiting PHASE2
-
Mar 2017 — Apr 2017 [monthly]
Recruiting PHASE2
-
Feb 2017 — Mar 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .